In China's tougher drug market, minnows open back door for 'Big Pharma'

SHANGHAI, April 29 (Reuters) - Armed with Beijing funds and friends in the right places, Chinese drug minnows are thriving, luring money from 'Big Pharma' majors struggling to restore the strong growth they once enjoyed in the world's second-largest medicine market.